Li N, Zhang Y, Zhang Q, Jin H, Han M, Guo J
Sci Rep. 2025; 15(1):8688.
PMID: 40082583
PMC: 11906761.
DOI: 10.1038/s41598-025-93512-5.
Asghariazar V, Makaremi S, Amani N, Zare E, Kadkhodayi M, Eterafi M
Sci Rep. 2025; 15(1):8239.
PMID: 40065071
PMC: 11894147.
DOI: 10.1038/s41598-025-92537-0.
Yi X, Cai H, Jiao Y
World J Gastrointest Surg. 2025; 17(2):100257.
PMID: 40061972
PMC: 11886003.
DOI: 10.4240/wjgs.v17.i2.100257.
Wang D, Tan M, Nov P
Int J Colorectal Dis. 2025; 40(1):60.
PMID: 40056174
PMC: 11890395.
DOI: 10.1007/s00384-025-04849-2.
Zhang C, Wang D, Shen Y, Zhang Y, Liu J
Cell Mol Life Sci. 2025; 82(1):100.
PMID: 40032765
PMC: 11876495.
DOI: 10.1007/s00018-025-05630-y.
The prealbumin-CD19 index predicts surgical survival in patients with GC.
Pan H, Sun H, Zuo Y, Zhao R, Xue Y, Song H
BMC Cancer. 2025; 25(1):359.
PMID: 40016677
PMC: 11866875.
DOI: 10.1186/s12885-025-13715-x.
Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways.
Papa V, Furci F, Minciullo P, Casciaro M, Allegra A, Gangemi S
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996790
PMC: 11854756.
DOI: 10.3390/cimb47020069.
Exosomal miR‑3681‑3p from M2‑polarized macrophages confers cisplatin resistance to gastric cancer cells by targeting MLH1.
Wei W, Li J, Huang J, Jiang Q, Lin C, Hu R
Mol Med Rep. 2025; 31(4).
PMID: 39981936
PMC: 11851060.
DOI: 10.3892/mmr.2025.13459.
Implication of protein post translational modifications in gastric cancer.
Song H, Zhang M, Guo C, Guo X, Ma Y, Ma Y
Front Cell Dev Biol. 2025; 13:1523958.
PMID: 39968176
PMC: 11833226.
DOI: 10.3389/fcell.2025.1523958.
The Role of Neural Network Analysis in Identifying Predictors of Gastric Cancer.
Siyam A
Acta Inform Med. 2025; 32(2):99-106.
PMID: 39959676
PMC: 11821569.
DOI: 10.5455/aim.2024.32.99-106.
Insufficient enteral nutrition is an independent risk factor for poor clinical outcomes in gastric cancer patients following radical gastrectomy.
Lv J, Li X, Li X, Wang M, Zhang Z, Wang D
Am J Transl Res. 2025; 17(1):320-329.
PMID: 39959201
PMC: 11826165.
DOI: 10.62347/HTYY3971.
Genomic landscape and potential therapeutic targets in alpha-fetoprotein-producing gastric cancer.
Zan L, Zhang X, Shen L, Zhao Q, Tan D, Peng X
Gastric Cancer. 2025; .
PMID: 39928247
DOI: 10.1007/s10120-025-01594-x.
Clinical and Prognostic Implications of an Alternative Splicing-related Risk Model Based on TP53 Status in Breast Cancer.
Wang X, Ye Z, Zhou L, Chen Y
Curr Pharm Biotechnol. 2025; 26(2):246-259.
PMID: 39916426
DOI: 10.2174/0113892010283176240212073417.
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies.
Luo D, Zhou J, Ruan S, Zhang B, Zhu H, Que Y
Cell Death Dis. 2025; 16(1):75.
PMID: 39915459
PMC: 11803115.
DOI: 10.1038/s41419-025-07385-7.
Spatiotemporal Correlation Analysis for the Incidence of Esophageal and Gastric Cancer From 2010 to 2019: Ecological Study.
Cui Z, Suo C, Zhao Y, Wang S, Zhao M, Chen R
JMIR Cancer. 2025; 11:e66655.
PMID: 39885591
PMC: 11798535.
DOI: 10.2196/66655.
Efficacy of the nutritional support team model in the management of patients undergoing total gastrectomy combined with Roux-en-Y anastomosis.
Su W, Yang Y, Wang Q, Zhang W
Pak J Med Sci. 2025; 41(1):141-146.
PMID: 39867765
PMC: 11755319.
DOI: 10.12669/pjms.41.1.11112.
Gastric cancer patient with amplification treated with crizotinib achieves long-term survival: a case report.
Xu W, Nie C, Wang H, Lv H, Chen B, Wang J
AME Case Rep. 2025; 9():27.
PMID: 39866270
PMC: 11761320.
DOI: 10.21037/acr-24-118.
Exploring the mediating role of blood metabolites in the relationship between gut microbiota and gastric cancer risk: a Mendelian randomization study.
Li X, Lin H, Peng J, Gong J
Front Cell Infect Microbiol. 2025; 14():1453286.
PMID: 39839262
PMC: 11747456.
DOI: 10.3389/fcimb.2024.1453286.
Coagulation indices and fibrinogen degradation products as predictive biomarkers for tumor-node-metastasis staging and metastasis in gastric cancer.
Shen Y, Wei Q, Tian Y, Ling Y, Zhang M
World J Gastrointest Oncol. 2025; 17(1):98725.
PMID: 39817145
PMC: 11664628.
DOI: 10.4251/wjgo.v17.i1.98725.
Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy.
Shi X, Song Y, Liang X, Chen T, Hao H, Han X
World J Gastrointest Oncol. 2025; 17(1):99272.
PMID: 39817128
PMC: 11664619.
DOI: 10.4251/wjgo.v17.i1.99272.